Chicago, IL, United States of America

Richard Edward Barnet Seftor

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Richard Edward Barnet Seftor: Innovator in Tumor Cell Research

Introduction

Richard Edward Barnet Seftor is a notable inventor based in Chicago, IL (US), recognized for his contributions to medical research and innovation. He holds a total of four patents, focusing primarily on methods to inhibit tumor cell aggressiveness using the microenvironment of human embryonic stem cells. His work has significant implications for cancer treatment and prevention.

Latest Patents

Seftor's latest patents include innovative methods that utilize factors derived from human embryonic stem cells (hESCs) to treat and prevent tumor formation and progression. One of his key inventions provides compositions comprising isolated factors from the microenvironment of hESCs, including Lefty and inhibitors of Nodal. These methods aim to inhibit tumor cell growth and treat aggressive tumors in mammals by administering effective amounts of inhibitors of Nodal activity.

Career Highlights

Throughout his career, Seftor has worked with prestigious institutions such as Children's Memorial Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago. His research has contributed to advancements in understanding tumor biology and developing therapeutic strategies.

Collaborations

Seftor has collaborated with notable colleagues, including Mary Jessica Hendrix and Elisabeth Ann Seftor, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Richard Edward Barnet Seftor's innovative work in tumor cell research exemplifies the potential of utilizing human embryonic stem cells in medical applications. His contributions continue to pave the way for advancements in cancer treatment and prevention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…